TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06389110: Phase III Clinical Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay the Progression of Myopia and Axial Ocular Elongation in Children.

Sponsor: Laboratorios Sophia S.A de C.V. · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 123 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$15,086,080

Rescue Site Savings

+$9,947,384

Unlock Full NCT06389110 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06389110 Rescue Dossier →